agilon health Reports First Quarter 2026 Results
agilon health reported Q1 2026 revenue of $1.42 billion, down 7% YoY, but significantly improved profitability with Adjusted EBITDA soaring to $54 million from $21 million a year ago. The company raised full-year 2026 guidance for total revenues to $5.68B-$5.805B, medical margin to $350M-$400M, and Adjusted EBITDA to $10M-$40M, citing strong ACO REACH performance and disciplined execution. agilon also announced the appointment of Tim O’Rourke as CEO, succeeding Executive Chairman Ronald A.
Key figures
- Eps
- 2.95
- Revenue
- $1.42 billion
- Guidance
- FY26 Revenue $5.68B-$5.805B (raised from $5.41B-$5.58B); FY26 Medical Margin $350M-$400M (raised from $300M-$350M); FY26 Adjusted EBITDA $10M-$40M (raised from $(15M)-$15M)
- Revenue Yoy
- -7%
- Net income
- 49000000
- Gross profit
- 65000000
- Total members
- 536000
- Medical margin
- 149000000
- Adjusted ebitda
- 54000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.